Pub. Date : 2013 Dec
PMID : 23996617
2 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Predictive value of ERCC1, ERCC2, and XRCC1 overexpression for stage III colorectal cancer patients receiving FOLFOX-4 adjuvant chemotherapy. | Folfox protocol | ERCC excision repair 1, endonuclease non-catalytic subunit | Homo sapiens |
| 2 | CONCLUSIONS: ERCC1 overexpression is an important predictor of early failure in patients with stage III CRC administrating FOLFOX-4 adjuvant chemotherapy and this marker may help identify patients who would benefit from intensive follow-up and enhance therapeutic programs. | Folfox protocol | ERCC excision repair 1, endonuclease non-catalytic subunit | Homo sapiens |